Overview
STIM market data
Price History
STIM price chart · 1M
- O
- 3.02
- H
- 3.04
- L
- 2.93
- C
- 2.97
- Vol
- 60,684.00
- Source
- US equities market feed
- Observed
- Aug 27, 2026, 12:00 AM
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $3.02
- Previous Close
- $2.99
- Day High
- $3.04
- Day Low
- $2.93
- 52 Week High
- $3.44
- 52 Week Low
- $1.12
- 7 Day Return
- -4.05%
- 30 Day Return
- +59.41%
- 90 Day Return
- +91.91%
- 1 Year Return
- +74.93%
- Daily Notional Volume
- $179.9K Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.59 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.19 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -24.5% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $0.80 – $3.71 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $249.9M · P/B 4.22 · P/S 1.65.
Company News
8-K filing — Neuronetics, Inc. (STIM)SEC EDGAR · Aug 17, 2026, 8:10 PM
BTIG Maintains Buy on Neuronetics, Raises Price Target to $6Benzinga · Aug 11, 2026, 6:00 PM
12 Health Care Stocks Moving In Tuesday's Intraday SessionBenzinga · Aug 11, 2026, 5:06 PM
Neuronetics shares are trading higher after the company reported better-than-expected Q2 financial results.Benzinga · Aug 11, 2026, 1:17 PM
Neuronetics Narrows FY2026 Sales Guidance from $160.000M-$166.000M to $160.000M-$164.000M vs $161.125M EstBenzinga · Aug 11, 2026, 11:59 AM
Neuronetics Q2 EPS $(0.05) Beats $(0.13) Estimate, Sales $41.568M Beat $40.175M EstimateBenzinga · Aug 11, 2026, 11:59 AM
Neuronetics Appoints Nir Naor CFO, Effective July 23,Benzinga · Jul 20, 2026, 8:05 PM
Why Is Neuronetics Stock Soaring Monday?Benzinga · Jul 20, 2026, 6:21 PM
Neuronetics shares are trading higher after BTIG initiated coverage on the stock with a Buy rating and announced a $5 price target.Benzinga · Jul 20, 2026, 2:42 PM
BTIG Initiates Coverage On Neuronetics with Buy Rating, Announces Price Target of $5Benzinga · Jul 20, 2026, 10:10 AM